Acrivon TherapeuticsACRV
那斯達克 · USD
1.38
-0.04
(-2.82%)
收盤 06/11 03:56 (UTC+8)
06/11 03:56 (UTC+8)
Acrivon TherapeuticsACRV
1.38
-0.04
(-2.82%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 19,902 | 20,116 | 19,687 | 22,649 | 21,662 | - | - | 21,437 | - | 21,053 |
研發費用 | 15,166 | 14,746 | 13,648 | 16,182 | 15,414 | 18,630 | 18,864 | 15,025 | 11,473 | 15,478 |
推銷及管理費用 | 4,736 | 5,370 | 6,039 | 6,467 | 6,248 | 6,324 | 6,276 | 6,412 | 6,195 | 5,575 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -19,902 | -20,116 | -19,687 | -22,649 | -21,662 | -24,954 | -25,140 | -21,437 | -17,668 | -21,053 |
其他收入及費用 | 860 | 1,131 | 1,453 | 1,643 | 1,982 | 2,123 | 2,699 | 2,639 | 1,182 | 1,801 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -19,042 | -18,985 | -18,234 | -21,006 | -19,680 | -22,831 | -22,441 | -18,798 | -16,486 | -19,252 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -19,042 | -18,985 | -18,234 | -21,006 | -19,680 | -22,831 | -22,441 | -18,798 | -16,486 | -19,252 |
基本每股稅後盈餘(元) | -0.49 | -0.49 | -0.47 | -0.55 | -0.51 | -0.60 | -0.59 | -0.52 | -0.73 | - |
稀釋每股稅後盈餘(元) | -0.49 | -0.49 | -0.47 | -0.55 | -0.51 | -0.59 | -0.59 | -0.47 | -0.73 | -0.87 |
基本平均股數(千股) | 38724.00 | 38666.00 | 38560.00 | 38461.00 | 38350.00 | 38242.00 | 38105.00 | 36132.00 | 22590.00 | - |
稀釋平均股數(千股) | 38724.00 | 38666.00 | 38560.00 | 38461.00 | 38350.00 | 38242.00 | 38105.00 | 36132.00 | 22590.00 | - |
還原基本每股稅後盈餘(元) | -0.49 | -0.49 | -0.47 | -0.55 | -0.51 | -0.60 | -0.59 | -0.52 | -0.73 | - |
還原稀釋每股稅後盈餘(元) | -0.49 | -0.49 | -0.47 | -0.55 | -0.51 | -0.59 | -0.59 | -0.47 | -0.73 | -0.87 |
還原基本平均股數(千股) | 38,724 | 38,666 | 38,560 | 38,461 | 38,350 | 38,242 | 38,105 | 36,132 | 22,590 | - |
還原稀釋平均股數(千股) | 38,724 | 38,666 | 38,560 | 38,461 | 38,350 | 38,242 | 38,105 | 36,132 | 22,590 | - |
EBITDA(千元) | -18,498 | -18,494 | -17,919 | -20,844 | -19,729 | -23,425 | -23,394 | -19,669 | -16,839 | -19,783 |